MIF T.Vaginalis

Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor), Phenylpyruvate Tautomerase, L-Dopachrome Tautomerase, L-Dopachrome Isomerase, GLIF, MMIF, GIF, Macrophage Migration Inhibitory Factor, Glycosylation-Inhibiting Factor, EC 5.3.3.12, EC 5.3.2.1, Macrophage migration inhibitory factor.

The cytokine Macrophage migration inhibitory factor (MIF) has been identified to be secreted by the pituitary gland and the monocyte/macrophage and to play an important role in endotoxic shock. MIF has the unique property of being released from macrophages and T cells in response to physiological concentrations of glucocorticoids. The secretion of MIF is tightly regulated and decreases at high, anti-inflammatory steroid concentration.

 MIF T.Vaginalis Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain (a.a 1-115) containing 121 amino acids including a 6 a.a C-terminal His tag. The total molecular mass is 13.4kDa (calculated). 

MIF T.Vaginalis filtered (0.4 µm) and lyophilized from 0.5mg/ml solution in 20 mM Tris buffer and 50 mM NaCl, pH 7.5.

It is recommended to add deionized water to prepare a working stock solution of approximately 0.5mg/ml and let the lyophilized pellet dissolve completely. MIF T.Vaginalis  is not sterile! Please filter the product by an appropriate sterile filter before using it in the cell culture.

Greater than 95.0% as determined by SDS-PAGE.

MPALVIKTNA KFTEEEKSKA TEELGNIVSK VLGKPISYVM VTLEDGVAVR FGGSDEKAAF MSLMSIGGLN RAVNKRASAA LTKWFTDHGF QGDRIYIVFN PKSAEDWGFN GDTFAHHHHH H.

SDS

ProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.